Skip to content

The effect and mechanism of Bifidobacterium catenulatum on improving anxiety and depression behaviors in IBD.

The effect and mechanism of Bifidobacterium catenulatum on improving anxiety and depression behaviors in IBD.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126366
Enrollment
Unknown
Registered
2026-06-08
Start date
2026-05-10
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Healthy control group:None

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Subjects voluntarily join the study and sign an informed consent form. 2. Subjects are aged 18-65 years, of any gender. 3. Group-Specific Inclusion Criteria: (1) UC Group: Meets the diagnostic criteria for UC in the "Consensus Opinion on the Diagnosis and Treatment of Inflammatory Bowel Disease"; Mayo score <= 5, in clinical remission or mild activity; no changes in dietary habits in the 3 months prior to enrollment. (2) Healthy Subject Group: Individuals undergoing health check-ups at our hospital with normal values for all indicators; no history of probiotic or antibiotic use within 4 weeks prior to enrollment; no history of digestive or mental disorders.

Exclusion criteria

Exclusion criteria: 1.Exclusion Criteria by Group: (1) UC Group: Comorbid Crohn's disease, intestinal tuberculosis, colorectal cancer, or other organic intestinal diseases; currently taking antidepressants/anti-anxiety medications or diagnosed with primary mental illness; comorbid severe heart, liver, or kidney insufficiency or other autoimmune diseases; pregnant or lactating women. (2) Healthy Subject Group: History of digestive tract diseases such as IBD or IBS; history of anxiety, depression, or significant stressful events in the past month; history of metabolic diseases or tumors; recent unhealthy lifestyle habits such as alcohol consumption or smoking.

Design outcomes

Primary

MeasureTime frame
Bifidobacterium catenulatum abundance;Severity of anxiety and depression;

Secondary

MeasureTime frame
Correlation between Bifidobacterium longum and anxiety and depression;

Countries

China

Contacts

Public ContactQing Shu

Shenzhen Second People's Hospital

sq6060@163.com+86 755 83366388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026